Shares of International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 3,725 shares changing hands.
International Stem Cell Trading Down 2.3 %
The stock’s fifty day moving average price is $0.09 and its 200 day moving average price is $0.08.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Stories
- Five stocks we like better than International Stem Cell
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Dividend Payout Ratio Calculator
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Insider Buying Explained: What Investors Need to Know
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20241015084625&h=45&w=95&zc=2){kind=logo}